Host Genetic Factors in the Clinical Course of HIV-1 Infection: Chemokines and Chemokine Receptors

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Public Health Genomics

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000065169PMID 12811024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of resistance to HIV infection

  2004cited by this paper
• [Vertical transmission of HIV-1].

  2002cited by this paper
• Estimated Global Distribution and Regional Spread of HIV‐1 Genetic Subtypes in the Year 2000

  2002cited by this paper
• Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data

  2001cited by this paper
• Characterization of high-risk HIV-1 seronegative hemophiliacs.

  2001cited by this paper
• Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

  2001cited by this paper
• Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

  2001cited by this paper
• Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression

  2001cited by this paper
• Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity

  2001cited by this paper
• Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.

  2001cited by this paper
• Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

  2000cited by this paper
• CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors

  2000cited by this paper
• Influence of CCR5 promoter haplotypes on AIDS progression in African–Americans

  2000cited by this paper
• Chemokines and their receptors in lymphocyte traffic and HIV infection.

  2000cited by this paper
• Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype

  2000cited by this paper
• HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1

  2000cited by this paper
• Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

  2000cited by this paper
• Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

  2000cited by this paper
• Chemokines: a new classification system and their role in immunity.

  2000cited by this paper
• In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

  2000cited by this paper
• Higher macrophage inflammatory protein (MIP)-1α and MIP-1β levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

  2000cited by this paper
• Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

  2000cited by this paper
• HIV-1 TRANSMISSION

  2000cited by this paper
• Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.

  2000cited by this paper
• Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

  2000cited by this paper
• Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1

  2000cited by this paper
• Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.

  2000cited by this paper
• CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.

  2000cited by this paper
• Genetic polymorphism in CX3CR1 and risk of HIV disease.

  2000cited by this paper
• Multiple nonfunctional alleles of CCR5 are frequent in various human populations.

  2000cited by this paper
• Maternal SDF1 3′A Polymorphism Is Associated with Increased Perinatal Human Immunodeficiency Virus Type 1 Transmission

  2000cited by this paper
• Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype

  2000cited by this paper
• Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.

  1999cited by this paper
• Naturally attenuated HIV--lessons for AIDS vaccines and treatment.

  1999cited by this paper
• Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.

  1999cited by this paper
• CCR2-64I Polymorphism Is Not Associated with Altered CCR5 Expression or Coreceptor Function

  1999cited by this paper
• Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression

  1999cited by this paper
• Frequency of a Mutated CCR-5 Allele (Delta32) among Italian Healthy Donors and Individuals at Risk of Parenteral HIV Infection

  1999cited by this paper
• Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

  1999cited by this paper
• A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants

  1999cited by this paper
• Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.

  1999cited by this paper
• Host genetic influences on HIV-1 pathogenesis.

  1999cited by this paper
• CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection.

  1999cited by this paper
• Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences.

  1999cited by this paper
• Chemokine control of HIV-1 infection

  1999cited by this paper
• Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene.

  1999cited by this paper
• Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis.

  1999cited by this paper
• HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

  1999cited by this paper
• Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.

  1999cited by this paper
• Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

  1999cited by this paper
• No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.

  1999cited by this paper
• Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques

  1999cited by this paper
• Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

  1999cited by this paper
• Chemokines and cell migration in secondary lymphoid organs.

  1999cited by this paper
• Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.

  1999cited by this paper
• Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.

  1999cited by this paper
• The immunogenetics of human infectious diseases.

  1998cited by this paper
• Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)

  1998cited by this paper
• Genetic acceleration of AIDS progression by a promoter variant of CCR5.

  1998cited by this paper
• A new classification for HIV-1

  1998cited by this paper
• Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

  1998cited by this paper
• Influence of host genes on HIV‐1 disease progression

  1998cited by this paper
• A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

  1998cited by this paper
• Chemokines and coreceptors in HIV/SIV-host interactions.

  1998cited by this paper
• CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.

  1998cited by this paper
• Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.

  1998cited by this paper
• Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

  1998cited by this paper
• The leukotriene B 4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD 4-positive cells

  1998cited by this paper
• The role of a stromal cell‐derived factor‐1 chemokine gene variant in the clinical course of HIV‐1 infection

  1998cited by this paper
• The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1

  1998cited by this paper
• The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.

  1998cited by this paper
• Cytokine Regulation of Human Immunodeficiency Virus Type 1 Entry and Replication in Human Monocytes/Macrophages through Modulation of CCR5 Expression

  1998cited by this paper
• CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

  1998cited by this paper
• Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population.

  1998cited by this paper
• A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness.

  1998cited by this paper
• An Orphan Seven-Transmembrane Domain Receptor Expressed Widely in the Brain Functions as a Coreceptor for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

  1998cited by this paper
• Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.

  1998cited by this paper
• Influence of the CCR 2V 64 I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR 2 b , CCR 3 , CCR 5 , and CXCR 4

  1998cited by this paper
• C-C chemokines, pivotal in protection against HIV type 1 infection.

  1998cited by this paper
• Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

  1998cited by this paper
• New infectious disease research funding

  1998cited by this paper
• Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.

  1998cited by this paper
• Genetic effects on HIV disease progression

  1998cited by this paper
• Chemokines and T lymphocytes: more than an attraction.

  1998cited by this paper
• Influence of the CCR2-V64I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR2b, CCR3, CCR5, and CXCR4

  1998cited by this paper
• The CC Chemokine I-309 Inhibits CCR8-dependent Infection by Diverse HIV-1 Strains*

  1998cited by this paper
• Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection

  1998cited by this paper
• Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.

  1998cited by this paper
• UvA-DARE (Digital Academic Repository) In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection

  1998cited by this paper
• Exclusive and Persistent Use of the Entry Coreceptor CXCR4 by Human Immunodeficiency Virus Type 1 from a Subject Homozygous for CCR5 Δ32

  1998cited by this paper
• Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.

  1998cited by this paper
• The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells.

  1998cited by this paper
• ChemR23, a putative chemoattractant receptor, is expressed in monocyte‐derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV‐1 strains

  1998cited by this paper
• Global distribution of the CCR5 gene 32-basepair deletion

  1997cited by this paper
• Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV infection and prognostic value of SI phenotype for survival after aids diagnoses

  1997cited by this paper
• HIV-1 infection in an individual homozygous for CCR5▵32

  1997cited by this paper
• HIV-1 infection in a man homozygous for CCR5▵32

  1997cited by this paper
• Expression cloning of new receptors used by simian and human immunodeficiency viruses

  1997cited by this paper
• CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

  1997cited by this paper
• CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status.

  1997cited by this paper

• HIV-1 isolation from infected peripheral blood mononuclear cells.

  2014cites this paper
• Human retroviruses

  2014cites this paper
• HIV-1 subtypes and coreceptor usage in a population from Northern Kenya

  2012cites this paper
• The Latitude Wise Prevalence of the CCR5-Δ32-HIV Resistance Allele in India

  2009influential citation
• The humoral immune response to HIV and its effect on virus replication and evolution

  2007cites this paper
• Het effect van single nucleotide polymorfismes in Trim5α op pathogenese van HIV-1 infectie

  2007cites this paper
• Determinants of host HIV-1 suspectibility and R5 HIV-1 evolution

  2004cites this paper
• Phenotypic and Genotypic Comparisons of CCR5- and CXCR4-Tropic Human Immunodeficiency Virus Type 1 Biological Clones Isolated from Subtype C-Infected Individuals

  2004cites this paper
• Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies

  2004cites this paper
• Biological and Molecular Aspects of HIV-1 Coreceptor Usage

  2003cites this paper
• Teratology Information Services in Europe and Their Contribution to the Prevention of Congenital Anomalies

  2002cites this paper